Insider Trading & Ownership - ROSS ROBERT W.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ROSS ROBERT W.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-08-01
Sale
2023-08-11
8:00 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Executive Officer
16,713$0.94$15,71083,193
(Direct)
View
2022-08-03
Sale
2022-08-05
8:00 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Executive Officer
10,594$1.72$18,22299,906
(Direct)
View
2021-07-21
Sale
2022-01-14
8:30 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Executive Officer
33,500$6.1$204,35054,500
(Direct)
View
2021-02-16
Sale
2021-02-18
8:00 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
1,000$11.35$11,35088,000
(Direct)
View
2021-01-14
Sale
2021-01-15
8:00 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
9,000$12.02$108,15089,000
(Direct)
View
2020-12-15
Sale
2020-12-17
8:00 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
1,000$10.48$10,48098,000
(Direct)
View
2020-12-11
Sale
2020-12-15
8:00 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
1,405$10.05$14,12099,000
(Direct)
View
2020-11-11
Sale
2020-11-13
8:00 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
595$10.05$5,980100,405
(Direct)
View
2020-10-14
Sale
2020-10-16
8:02 pm
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
4,000$10.05$40,200101,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-09-08
Disposition
2023-09-08
4:00 pm
N/A
N/A
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Executive Officer
483,193$00
(Direct)
View
2023-06-12
Option Award
2023-06-13
4:30 pm
N/A
2033-06-11
Xilio Therapeutics Inc.XLOROSS ROBERT W.
Director
13,200$013,200
(Direct)
View
2023-03-01
Option Award
2023-03-03
8:00 pm
N/A
2033-03-01
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Executive Officer
400,000$0400,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:08 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOROSS ROBERT W.
Director
26,400$026,400
(Direct)
View
2022-03-01
Option Award
2022-03-03
8:00 pm
N/A
2032-03-01
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Executive Officer
415,000$0469,500
(Direct)
View
2021-02-12
Option Award(A)
2021-03-11
8:00 pm
N/A
2031-02-12
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
484,280$0484,280
(Direct)
View
2021-02-12
Option Award
2021-03-03
8:18 pm
N/A
2031-02-12
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
484,280$0484,280
(Direct)
View
2020-02-03
Option Award
2020-02-05
4:05 pm
N/A
2030-02-03
Surface Oncology Inc.SURFROSS ROBERT W.
Chief Medical Officer
80,000$0185,000
(Direct)
View
(A) Indicate amendment filing.